Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Craniopharyngioma.

Matthew R Garnett1, Stéphanie Puget, Jacques Grill

  • 1Department of Paediatric Neurosurgery, Necker Hospital for Sick Children, Paris, France. mrgarnett@doctors.org.uk

Orphanet Journal of Rare Diseases
|April 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Metabolic Risk in Childhood Brain Cancer Survivors with Childhood-Onset Growth Hormone Deficiency.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Correction: Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study.

Journal of cancer survivorship : research and practice·2026
Same author

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

Nature medicine·2026
Same author

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Acta neuropathologica communications·2026
Same author

Assessment of everyday executive functioning in children and adolescents treated for childhood noncentral nervous system solid tumor.

Neuropsychology·2026
Same author

Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study.

Journal of cancer survivorship : research and practice·2026
Same journal

Increased awareness around an ultra-rare disease can improve diagnosis delays: the French example in primary hyperoxalurias.

Orphanet journal of rare diseases·2026
Same journal

Patient-driven surveys of mucopolysaccharidoses revealed patient-reported outcomes in the Japan MPS patient and family group.

Orphanet journal of rare diseases·2026
Same journal

Mapping the landscape of treatable inborn errors of metabolism: a systematic gene-level evaluation based on the ICIMD classification.

Orphanet journal of rare diseases·2026
Same journal

Cognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study.

Orphanet journal of rare diseases·2026
Same journal

Real-world insights into neurodevelopmental outcomes amongst people with congenital hyperinsulinism.

Orphanet journal of rare diseases·2026
Same journal

Care of patients with Phenylketonuria (PKU) in Germany - a claims data analysis from 2013 to 2023.

Orphanet journal of rare diseases·2026
See all related articles

Craniopharyngiomas are slow-growing tumors in the brain

Area of Science:

  • Neuro-oncology
  • Endocrinology
  • Pathology

Background:

  • Craniopharyngiomas are benign, slow-growing tumors originating in the sellar/parasellar region of the central nervous system.
  • They affect approximately 2 in 100,000 individuals, often presenting with insidious neurological and endocrine symptoms.
  • Tumor origins are linked to epithelial remnants of the craniopharyngeal duct or Rathke's pouch.

Purpose of the Study:

  • To provide a comprehensive overview of craniopharyngiomas, covering their diagnosis, treatment, and outcomes.
  • To highlight the diagnostic challenges and differential diagnoses for sellar region tumors.

Main Methods:

  • Diagnosis relies on neuroradiological findings (cystic, solid, calcified components) and histological examination.
  • Differential diagnosis includes pituitary adenomas, inflammatory processes, vascular malformations, and congenital anomalies.

Related Experiment Videos

  • Treatment involves surgical resection (gross total or subtotal) with potential post-operative radiotherapy.

    • Main Results:

    • Surgical resection is the primary treatment, with radiotherapy used in cases of hypothalamic invasion.
    • Endocrine dysfunctions are typically permanent and require lifelong hormone replacement.
    • The 5-year survival rate is approximately 80%, but morbidity, including hypothalamic dysfunction, is common.

    Conclusions:

    • Craniopharyngiomas necessitate a multidisciplinary approach for optimal management.
    • Long-term endocrine and neuropsychological monitoring is crucial for patients.
    • Despite advancements, craniopharyngiomas present significant challenges due to their location and potential for morbidity.